Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2017, Article ID 3402808, 6 pages
https://doi.org/10.1155/2017/3402808
Clinical Study

STK11 rs2075604 Polymorphism Is Associated with Metformin Efficacy in Chinese Type 2 Diabetes Mellitus

1Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, China
2Institute of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Central South University, Changsha 410078, China
3Department of Medical Center Transformation, Zhengzhou Central Hospital, Zhengzhou University, Zhengzhou 450007, China
4Department of Key Laboratory of Endocrinology, Zhengzhou Central Hospital, Zhengzhou University, Zhengzhou 450007, China

Correspondence should be addressed to Zhi Li; moc.361@984ihzil

Received 22 December 2016; Revised 6 April 2017; Accepted 26 April 2017; Published 9 July 2017

Academic Editor: Mario Maggi

Copyright © 2017 Qingchu Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. G. Graham, J. Punt, M. Arora et al., “Clinical pharmacokinetics of metformin,” Clinical Pharmacokinetics, vol. 50, pp. 81–98, 2011. View at Google Scholar
  2. G. Zhou, R. Myers, Y. Li et al., “Role of AMP-activated protein kinase in mechanism of metformin action,” The Journal of Clinical Investigation, vol. 108, pp. 1167–1174, 2001. View at Google Scholar
  3. F. A. Duca, C. D. Cote, B. A. Rasmussen et al., “Metformin activates a duodenal Ampk-dependent pathway to lower hepatic glucose production in rats,” Nature Medicine, vol. 21, pp. 506–511, 2015. View at Google Scholar
  4. U.P.D.S. Group, “Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34),” Lancet, vol. 352, pp. 854–865, 1998. View at Google Scholar
  5. L. Tarasova, I. Kalnina, K. Geldnere et al., “Association of genetic variation in the organic cation transporters OCT1, OCT2 and multidrug and toxin extrusion 1 transporter protein genes with the gastrointestinal side effects and lower BMI in metformin-treated type 2 diabetes patients,” Pharmacogenetics and Genomics, vol. 22, pp. 659–666, 2012. View at Google Scholar
  6. D. Xiao, Y. Guo, X. Li et al., “The impacts of SLC22A1 rs594709 and SLC47A1 rs2289669 polymorphisms on metformin therapeutic efficacy in Chinese type 2 diabetes patients,” International Journal of Endocrinology, vol. 2016, Article ID 4350712, 7 pages, 2016. View at Google Scholar
  7. G. Umamaheswaran, R. G. Praveen, S. E. Damodaran, A. K. Das, and C. Adithan, “Influence of SLC22A1 rs622342 genetic polymorphism on metformin response in South Indian type 2 diabetes mellitus patients,” Clinical and Experimental Medicine, vol. 15, pp. 511–517, 2015. View at Google Scholar
  8. A. Mahrooz, H. Parsanasab, M. B. Hashemi-Soteh et al., “The role of clinical response to metformin in patients newly diagnosed with type 2 diabetes: a monotherapy study,” Clinical and Experimental Medicine, vol. 15, pp. 159–165, 2015. View at Google Scholar
  9. D. Xiao, S. Zhang, X. Li et al., “IL-1B rs1143623 and EEF1A1P11-RPL7P9 rs10783050 polymorphisms affect the glucose-lowing efficacy of metformin in Chinese overweight or obese type 2 diabetes mellitus patients,” Pharmacogenomics, vol. 16, pp. 1621–1629, 2015. View at Google Scholar
  10. A. Woods, S. R. Johnstone, K. Dickerson et al., “LKB1 is the upstream kinase in the AMP-activated protein kinase cascade,” Current Biology, vol. 13, pp. 2004–2008, 2003. View at Google Scholar
  11. R. S. Legro, H. X. Barnhart, W. D. Schlaff et al., “Ovulatory response to treatment of polycystic ovary syndrome is associated with a polymorphism in the STK11 gene,” The Journal of Clinical Endocrinology and Metabolism, vol. 93, pp. 792–800, 2008. View at Google Scholar
  12. J. Bassols, A. Megia, P. Soriano-Rodriguez et al., “A common gene variant in STK11 is associated with metabolic risk markers and diabetes during gestation,” Fertility and Sterility, vol. 100, pp. 788–792, 2013. View at Google Scholar
  13. R. J. Shaw, K. A. Lamia, D. Vasquez et al., “The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin,” Science, vol. 310, pp. 1642–1646, 2005. View at Google Scholar
  14. P. H. Bennett, “Impact of the new WHO classification and diagnostic criteria,” Diabetes, Obesity & Metabolism, vol. 1, Supplement 2, pp. S1–S6, 1999. View at Google Scholar
  15. WHO, Global Report on Diabetes, WHO Press, Switzerland, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Weng, “Evolution in the Chinese diabetes society standards of care for type 2 diabetes,” Diabetes/Metabolism Research and Reviews, vol. 32, pp. 440-441, 2016. View at Google Scholar
  17. J. J. Chamberlain, A. S. Rhinehart, C. J. Shaefer, and A. Neuman, “Diagnosis and management of diabetes: synopsis of the 2016 American Diabetes Association Standards of Medical Care in Diabetes,” Annals of Internal Medicine, vol. 164, pp. 542–552, 2016. View at Google Scholar
  18. M. Kone, T. J. Pullen, G. Sun et al., “LKB1 and AMPK differentially regulate pancreatic beta-cell identity,” The FASEB Journal, vol. 28, pp. 4972–4985, 2014. View at Google Scholar
  19. S. Bang, Y. Chen, R. S. Ahima, and S. F. Kim, “Convergence of IPMK and LKB1-AMPK signaling pathways on metformin action,” Molecular Endocrinology, vol. 28, pp. 1186–1193, 2014. View at Google Scholar
  20. T. Shan, P. Zhang, P. Bi, and S. Kuang, “Lkb1 deletion promotes ectopic lipid accumulation in muscle progenitor cells and mature muscles,” Journal of Cellular Physiology, vol. 230, pp. 1033–1041, 2015. View at Google Scholar
  21. D. G. Hardie and D. R. Alessi, “LKB1 and AMPK and the cancer-metabolism link - ten years after,” BMC Biology, vol. 11, p. 36, 2013. View at Google Scholar
  22. G. L. Russo, M. Russo, and P. Ungaro, “AMP-activated protein kinase: a target for old drugs against diabetes and cancer,” Biochemical Pharmacology, vol. 86, pp. 339–350, 2013. View at Google Scholar
  23. A. Lopez-Bermejo, M. Diaz, E. Moran, F. Zegher, and L. Ibáñez, “A single nucleotide polymorphism in STK11 influences insulin sensitivity and metformin efficacy in hyperinsulinemic girls with androgen excess,” Diabetes Care, vol. 33, pp. 1544–1548, 2010. View at Google Scholar